<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="010578-2018"
            EDITION="2018006">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-008774-001</RECEPTION_ID>
      <DELETION_DATE>20180214</DELETION_DATE>
      <FORM_LG_LIST>EN </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>6</NO_OJ>
         <DATE_PUB>20180110</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 006-010578</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="EN">http://ted.europa.eu/udl?uri=TED:NOTICE:010578-2018:TEXT:EN:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>EN</LG_ORIG>
         <ISO_COUNTRY VALUE="NO"/>
         <IA_URL_GENERAL>http://www.fhi.no</IA_URL_GENERAL>
         <IA_URL_ETENDERING>https://tendsign.no/doc.aspx?UniqueId=afxrqkhzbc&amp;GoTo=Docs</IA_URL_ETENDERING>
         <ORIGINAL_CPV CODE="33600000">Pharmaceutical products</ORIGINAL_CPV>
         <ORIGINAL_CPV CODE="33000000">Medical equipments, pharmaceuticals and personal care products</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="NO">NORGE</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="NO">NORGE</n2016:CA_CE_NUTS>
         <REF_NOTICE>
            <NO_DOC_OJS>2017/S 175-359733</NO_DOC_OJS>
         </REF_NOTICE>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180108</DS_DATE_DISPATCH>
         <DT_DATE_FOR_SUBMISSION>20180214 13:00</DT_DATE_FOR_SUBMISSION>
         <AA_AUTHORITY_TYPE CODE="N">National or federal Agency/Office</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="3">Contract notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="B">European Economic Area (EEA), with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="1">Submission for all lots</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="2">The most economic tender</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES>
         <HEADING>03B02</HEADING>
         <INITIATOR>03</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Норвегия</TI_CY>
            <TI_TOWN>Осло</TI_TOWN>
            <TI_TEXT>
               <P>Фармацевтични продукти</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Norsko</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Léčivé přípravky a zdravotnické prostředky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Norge</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Lægemidler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Norwegen</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Arzneimittel</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Νορβηγία</TI_CY>
            <TI_TOWN>Όσλο</TI_TOWN>
            <TI_TEXT>
               <P>Φαρμακευτικά προϊόντα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>Norway</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Noruega</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Productos farmacéuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Norra</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Ravimid</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Norja</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Farmaseuttiset tuotteet</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Norvège</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Produits pharmaceutiques</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Iorua, an</TI_CY>
            <TI_TOWN>Osló</TI_TOWN>
            <TI_TEXT>
               <P>Pharmaceutical products</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Norveška</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Norvégia</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Gyógyszerészeti termékek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Norvegia</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaceutici</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Norvegija</TI_CY>
            <TI_TOWN>Oslas</TI_TOWN>
            <TI_TEXT>
               <P>Farmacijos produktai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Norvēģija</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Farmācijas izstrādājumi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>in-Norveġja</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Prodotti farmaċewtiċi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Noorwegen</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutische producten</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Norwegia</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Produkty farmaceutyczne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Noruega</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Produtos farmacêuticos</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Norvegia</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Produse farmaceutice</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Nórsko</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Farmaceutické výrobky</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Norveška</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Farmacevtski proizvodi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Norge</TI_CY>
            <TI_TOWN>Oslo</TI_TOWN>
            <TI_TEXT>
               <P>Läkemedel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="EN">Folkehelseinstituttet</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F02_2014 CATEGORY="ORIGINAL" FORM="F02" LG="EN">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>Folkehelseinstituttet</OFFICIALNAME>
               <NATIONALID>983 744 516</NATIONALID>
               <ADDRESS>Lovisenberggata 8</ADDRESS>
               <TOWN>Oslo</TOWN>
               <POSTAL_CODE>0456</POSTAL_CODE>
               <COUNTRY VALUE="NO"/>
               <CONTACT_POINT>Babek Saifalsadaty</CONTACT_POINT>
               <E_MAIL>babek.saifalsadaty@nhn.no</E_MAIL>
               <n2016:NUTS CODE="NO"/>
               <URL_GENERAL>http://www.fhi.no</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY>
            <DOCUMENT_FULL/>
            <URL_DOCUMENT>https://tendsign.no/doc.aspx?UniqueId=afxrqkhzbc&amp;GoTo=Docs</URL_DOCUMENT>
            <ADDRESS_FURTHER_INFO_IDEM/>
            <URL_PARTICIPATION>https://tendsign.no/doc.aspx?UniqueId=afxrqkhzbc&amp;GoTo=Tender</URL_PARTICIPATION>
            <CA_TYPE VALUE="NATIONAL_AGENCY"/>
            <CA_ACTIVITY VALUE="HEALTH"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Flu pandemic vaccines</P>
            </TITLE>
            <REFERENCE_NUMBER>17/04327</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33600000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>The Norwegian Institute of Public Health (FHI) is planning, on behalf of the Ministry of Health and Care Services (HOD), to hold an open tender contest for the procurement of vaccines against pandemic influensa for the Norwegian population. The intention of this procurement is to ensure inhabitants in Norway access to the vaccination in the event of pandemic influensa in the contract period.</P>
            </SHORT_DESCR>
            <NO_LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <CPV_ADDITIONAL>
                  <CPV_CODE CODE="33000000"/>
               </CPV_ADDITIONAL>
               <n2016:NUTS CODE="NO"/>
               <SHORT_DESCR>
                  <P>The Norwegian Institute of Public Health (FHI) is planning, on behalf of the Ministry of Health and Care Services (HOD), to hold an open tender contest for the procurement of vaccines against pandemic influensa for the Norwegian population. The intention of this procurement is to ensure inhabitants in Norway access to the vaccination in the event of pandemic influensa in the contract period.</P>
               </SHORT_DESCR>
               <AC_PROCUREMENT_DOC/>
               <DATE_START>2018-06-24</DATE_START>
               <DATE_END>2022-06-24</DATE_END>
               <RENEWAL/>
               <RENEWAL_DESCR>
                  <P>1 extension of 12 months.</P>
               </RENEWAL_DESCR>
               <NO_ACCEPTED_VARIANTS/>
               <OPTIONS/>
               <OPTIONS_DESCR>
                  <P>Option for procurement of flu pandemic vaccines during the contract period.</P>
                  <P>If only one valid tender to the contest is received, the contracting authority has the option to award a contract for 100 % of the volume to 1 tenderer.</P>
                  <P>The contracting authority has an option to extend the contract period with 1 year if pandemic influenza breaks out during the last year of the agreement.</P>
               </OPTIONS_DESCR>
               <NO_EU_PROGR_RELATED/>
               <INFO_ADD>
                  <P>The option for 1 year extension of the contract is an exception and will only be valid if pandemic influenza emerges during the last year of the agreement. This option for extension is due to public health preparedness.</P>
               </INFO_ADD>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <LEFTI>
            <SUITABILITY>
               <P>Requirement: tenderers shall be a legally established company.</P>
               <P>Documentation: Company registration certificate(s) in accordance with the legislation in the country where the tenderer is established.</P>
            </SUITABILITY>
            <ECONOMIC_CRITERIA_DOC/>
            <TECHNICAL_CRITERIA_DOC/>
            <PERFORMANCE_CONDITIONS>
               <P>The contractual terms are attached to the tender contest.</P>
            </PERFORMANCE_CONDITIONS>
         </LEFTI>
         <PROCEDURE>
            <PT_OPEN/>
            <FRAMEWORK>
               <SEVERAL_OPERATORS/>
               <NB_PARTICIPANTS>2</NB_PARTICIPANTS>
               <JUSTIFICATION>The initial contract period is only 4 years. If a pandemic influenza breakout during the fourth year of the contract period, the contracting authority has, due to public health preparedness, an option to extend the contract with 1 year.</JUSTIFICATION>
            </FRAMEWORK>
            <CONTRACT_COVERED_GPA/>
            <NOTICE_NUMBER_OJ>2017/S 175-359733</NOTICE_NUMBER_OJ>
            <DATE_RECEIPT_TENDERS>2018-02-14</DATE_RECEIPT_TENDERS>
            <TIME_RECEIPT_TENDERS>13:00</TIME_RECEIPT_TENDERS>
            <LANGUAGES>
               <LANGUAGE VALUE="EN"/>
               <LANGUAGE VALUE="NO"/>
            </LANGUAGES>
            <DATE_TENDER_VALID>2018-08-14</DATE_TENDER_VALID>
            <OPENING_CONDITION>
               <DATE_OPENING_TENDERS>2018-02-14</DATE_OPENING_TENDERS>
               <TIME_OPENING_TENDERS>14:00</TIME_OPENING_TENDERS>
            </OPENING_CONDITION>
         </PROCEDURE>
         <COMPLEMENTARY_INFO>
            <NO_RECURRENT_PROCUREMENT/>
            <INFO_ADD>
               <P>Visma notice: https://opic.com/id/afxrqkhzbc</P>
            </INFO_ADD>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Klagenemnda for offentlige anskaffelser</OFFICIALNAME>
               <TOWN>Bergen</TOWN>
               <COUNTRY VALUE="NO"/>
            </ADDRESS_REVIEW_BODY>
            <DATE_DISPATCH_NOTICE>2018-01-08</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F02_2014>
   </FORM_SECTION>
</TED_EXPORT>
